(19)
(11) EP 2 087 899 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.10.2011 Bulletin 2011/41

(45) Mention of the grant of the patent:
17.08.2011 Bulletin 2011/33

(21) Application number: 07831090.1

(22) Date of filing: 26.10.2007
(51) International Patent Classification (IPC): 
A61K 36/07(2006.01)
A23L 1/30(2006.01)
A61P 31/16(2006.01)
 A23K 1/16(2006.01)
A23L 2/38(2006.01)
A61P 43/00(2006.01)
(86) International application number:
PCT/JP2007/071356
(87) International publication number:
WO 2008/050910 (02.05.2008 Gazette 2008/18)

(54)

GRIFOLA FRONDOSA-DERIVED SUBSTANCE HAVING ANTI-INFLUENZA VIRUS ACTIVITY AND METHOD FOR PRODUCING THE SAME

SUBSTANZ AUS GRIFOLA FRONDOSA MIT WIRKUNG GEGEN DAS INFLUENZA-VIRUS UND HERSTELLUNGSVERFAHREN DAFÜR

SUBSTANCE DERIVEE DE GRIFOLA FRONDOSA AYANT UNE ACTIVITE CONTRE LE VIRUS DE LA GRIPPE ET PROCEDE DE PRODUCTION DE CETTE SUBSTANCE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 27.10.2006 JP 2006292091

(43) Date of publication of application:
12.08.2009 Bulletin 2009/33

(73) Proprietor: Yukiguni Maitake Co., Ltd.
Minami-Uonuma-shi, Niigata 949-6695 (JP)

(72) Inventors:
  • WATANABE, Masataka
    Utsunomiya-shi Tochigi 3210343 (JP)
  • TAKEYAMA, Masahide
    Saitama-shi Saitama 3310063 (JP)

(74) Representative: Schwahn, Hartmut et al
Gleiss Grosse Schrell & Partner Patentanwälte Rechtsanwälte Leitzstraße 45
70469 Stuttgart
70469 Stuttgart (DE)


(56) References cited: : 
EP-A1- 0 893 449
JP-A- 2005 132 810
 JP-A- 6 312 934
JP-A- 2007 031 665
   
  • DATABASE WPI Week 200538 Thomson Scientific, London, GB; AN 2005-369337 XP002568343 & JP 2005 132810 A (SEIMEI KAGAKU KENKYUSHO YG) 26 May 2005 (2005-05-26)
  • MASUDA Y. ET AL.: 'Grifola frondosa Ganyu glycoprotein(MZ-Fraction) no in vitro ni okeru macrophage J774.1 Saibo no Kasseika' PROCEEDINGS OF THE ANNUAL MEETING OF THE PHARMACEUTICAL SOCIETY OF JAPAN vol. 125TH, no. 3, 2005, page 37, XP003022397
  • ZHUANG C. ET AL.: 'Host-mediated antitumor polysaccharides. XVIII. Detailed fractionation and antitumor activity of the mycelial polysaccharides from liquid culture of Grifola frondosa' SHIZUOKA DAIGAKU NOGAKUBU KENKYU HOKOKU vol. 42, 1993, pages 43 - 58, XP003022398
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).